182 related articles for article (PubMed ID: 27986811)
21. Dickkopf-1 inhibits thyroid cancer cell survival and migration through regulation of β-catenin/E-cadherin signaling.
Cho SW; Lee EJ; Kim H; Kim SH; Ahn HY; Kim YA; Yi KH; Park DJ; Shin CS; Ahn SH; Cho BY; Park YJ
Mol Cell Endocrinol; 2013 Feb; 366(1):90-8. PubMed ID: 23261982
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
[TBL] [Abstract][Full Text] [Related]
23. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
[TBL] [Abstract][Full Text] [Related]
24. Ginsenoside Rg3 Inhibition of Thyroid Cancer Metastasis Is Associated with Alternation of Actin Skeleton.
Wu W; Zhou Q; Zhao W; Gong Y; Su A; Liu F; Liu Y; Li Z; Zhu J
J Med Food; 2018 Sep; 21(9):849-857. PubMed ID: 30136914
[TBL] [Abstract][Full Text] [Related]
25. EphB3 receptor suppressor invasion, migration and proliferation in glioma by inhibiting EGFR-PI3K/AKT signaling pathway.
Xiao Z; Huang S; Qiu W; Pang M; Zeng X; Xu X; Yang Y; Yang B; Chu L
Brain Res; 2024 May; 1830():148796. PubMed ID: 38341169
[TBL] [Abstract][Full Text] [Related]
26. Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness.
Zhang T; Shen X; Liu R; Zhu G; Bishop J; Xing M
Oncotarget; 2017 Jan; 8(1):900-914. PubMed ID: 27863429
[TBL] [Abstract][Full Text] [Related]
27. MST3 promotes proliferation and tumorigenicity through the VAV2/Rac1 signal axis in breast cancer.
Cho CY; Lee KT; Chen WC; Wang CY; Chang YS; Huang HL; Hsu HP; Yen MC; Lai MZ; Lai MD
Oncotarget; 2016 Mar; 7(12):14586-604. PubMed ID: 26910843
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo.
Meng W; Wang PS; Liu J; Xue S; Wang GM; Meng XY; Chen G
Oncol Rep; 2014 Dec; 32(6):2411-20. PubMed ID: 25231838
[TBL] [Abstract][Full Text] [Related]
29. Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.
Heo J; Thapar R; Campbell SL
Biochemistry; 2005 May; 44(17):6573-85. PubMed ID: 15850391
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene.
Li T; Yang XD; Ye CX; Shen ZL; Yang Y; Wang B; Guo P; Gao ZD; Ye YJ; Jiang KW; Wang S
Cell Cycle; 2017 Jan; 16(2):224-231. PubMed ID: 27929737
[TBL] [Abstract][Full Text] [Related]
31. VEGF-induced Rac1 activation in endothelial cells is regulated by the guanine nucleotide exchange factor Vav2.
Garrett TA; Van Buul JD; Burridge K
Exp Cell Res; 2007 Sep; 313(15):3285-97. PubMed ID: 17686471
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer.
Sun W; Lan X; Wang Z; Dong W; He L; Zhang T; Zhang H
Med Oncol; 2016 Sep; 33(9):102. PubMed ID: 27510368
[TBL] [Abstract][Full Text] [Related]
34. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
35. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.
Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M
PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of homocysteine-induced Rac1/NADPH oxidase activation in mesangial cells: role of guanine nucleotide exchange factor Vav2.
Yi F; Chen QZ; Jin S; Li PL
Cell Physiol Biochem; 2007; 20(6):909-18. PubMed ID: 17982273
[TBL] [Abstract][Full Text] [Related]
37. The role of Slit2 as a tumor suppressor in thyroid cancer.
Jeon MJ; Lim S; You MH; Park Y; Song DE; Sim S; Kim TY; Shong YK; Kim WB; Kim WG
Mol Cell Endocrinol; 2019 Mar; 483():87-96. PubMed ID: 30648543
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
[TBL] [Abstract][Full Text] [Related]
39. Aurora kinase A induces papillary thyroid cancer lymph node metastasis by promoting cofilin-1 activity.
Maimaiti Y; Jie T; Jing Z; Changwen W; Pan Y; Chen C; Tao H
Biochem Biophys Res Commun; 2016 Apr; 473(1):212-218. PubMed ID: 27003257
[TBL] [Abstract][Full Text] [Related]
40. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
